Insulet outlines 21%–23% Omnipod revenue growth for 2026 with operating margin expansion, driven by global adoption and product innovation [Seeking Alpha]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Seeking Alpha
Ashley McEvoy, CEO, reported "we closed 2025 with another strong quarter, recording our 10th consecutive year of 20% or greater constant currency revenue growth," citing durable recurring revenue and a profitable business model as key drivers. She Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Insulet cites technology lead, broad access, and strong clinical data as key sustainable differentiators but notes 2026 growth will moderate due to tough comparisons and influx of competitors; management emphasizes investment in R&D and manufacturing to protect market position. Growth is driven by new customer starts, particularly type 2 diabetes conversion from multiple daily injections, clinical value, international expansion, and expansion of a broad prescriber base; upcoming launches and CGM integrations are also expected growth catalysts. Insulet projects
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..MarketBeat
- Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $380.00 price target on the stock.MarketBeat
- Insulet Corp (PODD) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- Insulet (PODD) Shares Skyrocket, What You Need To Know [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 2/18/26 - Beat
PODD
Sec Filings
- 2/18/26 - Form 10-K
- 2/18/26 - Form 8-K
- 2/17/26 - Form 4
- PODD's page on the SEC website